Literature DB >> 20853438

Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).

Michael C Kruer1, Coro Paisán-Ruiz, Nathalie Boddaert, Moon Y Yoon, Hiroko Hama, Allison Gregory, Alessandro Malandrini, Randall L Woltjer, Arnold Munnich, Stephanie Gobin, Brenda J Polster, Silvia Palmeri, Simon Edvardson, John Hardy, Henry Houlden, Susan J Hayflick.   

Abstract

OBJECTIVE: Neurodegeneration with brain iron accumulation (NBIA) represents a distinctive phenotype of neurodegenerative disease for which several causative genes have been identified. The spectrum of neurologic disease associated with mutations in NBIA genes is broad, with phenotypes that range from infantile neurodegeneration and death in childhood to adult-onset parkinsonism-dystonia. Here we report the discovery of a novel gene that leads to a distinct form of NBIA.
METHODS: Using autozygosity mapping and candidate gene sequencing, we identified mutations in the fatty acid hydroxylase gene FA2H, newly implicating abnormalities of ceramide metabolism in the pathogenesis of NBIA.
RESULTS: Neuroimaging demonstrated T2 hypointensity in the globus pallidus, confluent T2 white matter hyperintensities, and profound pontocerebellar atrophy in affected members of two families. Phenotypically, affected family members exhibited spastic quadriparesis, ataxia, and dystonia with onset in childhood and episodic neurological decline. Analogous to what has been reported previously for PLA2G6, the phenotypic spectrum of FA2H mutations is diverse based on our findings and those of prior investigators, because FA2H mutations have been identified in both a form of hereditary spastic paraplegia (SPG35) and a progressive familial leukodystrophy.
INTERPRETATION: These findings link white matter degeneration and NBIA for the first time and implicate new signaling pathways in the genesis of NBIA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853438      PMCID: PMC6059612          DOI: 10.1002/ana.22122

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

Review 1.  Fatty acid 2-Hydroxylation in mammalian sphingolipid biology.

Authors:  Hiroko Hama
Journal:  Biochim Biophys Acta       Date:  2009-12-21

2.  Sea-blue histiocytes, lymphocytic cytosomes, movement disorder and 59Fe-uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan?

Authors:  K F Swaiman; S A Smith; G L Trock; A R Siddiqui
Journal:  Neurology       Date:  1983-03       Impact factor: 9.910

3.  Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.

Authors:  Inge Zöller; Marion Meixner; Dieter Hartmann; Heinrich Büssow; Rainer Meyer; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

4.  The human FA2H gene encodes a fatty acid 2-hydroxylase.

Authors:  Nathan L Alderson; Barbara M Rembiesa; Michael D Walla; Alicja Bielawska; Jacek Bielawski; Hiroko Hama
Journal:  J Biol Chem       Date:  2004-08-27       Impact factor: 5.157

5.  Critical role of iron in the pathogenesis of the murine gangliosidoses.

Authors:  Mylvaganam Jeyakumar; Ian Williams; David Smith; Timothy M Cox; Frances M Platt
Journal:  Neurobiol Dis       Date:  2009-06       Impact factor: 5.996

Review 6.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

7.  Neurodegeneration associated with genetic defects in phospholipase A(2).

Authors:  A Gregory; S K Westaway; I E Holm; P T Kotzbauer; P Hogarth; S Sonek; J C Coryell; T M Nguyen; N Nardocci; G Zorzi; D Rodriguez; I Desguerre; E Bertini; A Simonati; B Levinson; C Dias; C Barbot; I Carrilho; M Santos; I Malik; J Gitschier; S J Hayflick
Journal:  Neurology       Date:  2008-09-17       Impact factor: 9.910

8.  Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia.

Authors:  Simon Edvardson; Hiroko Hama; Avraham Shaag; John Moshe Gomori; Itai Berger; Dov Soffer; Stanley H Korman; Ilana Taustein; Ann Saada; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2008-11       Impact factor: 11.025

Review 9.  Application of genome-wide single nucleotide polymorphism typing: simple association and beyond.

Authors:  J Raphael Gibbs; Andrew Singleton
Journal:  PLoS Genet       Date:  2006-10-06       Impact factor: 5.917

Review 10.  Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease.

Authors:  Jose Bras; Andrew Singleton; Mark R Cookson; John Hardy
Journal:  FEBS J       Date:  2008-12       Impact factor: 5.542

View more
  69 in total

1.  Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration.

Authors:  Tyler Mark Pierson; Dimitre R Simeonov; Murat Sincan; David A Adams; Thomas Markello; Gretchen Golas; Karin Fuentes-Fajardo; Nancy F Hansen; Praveen F Cherukuri; Pedro Cruz; James C Mullikin; Craig Blackstone; Cynthia Tifft; Cornelius F Boerkoel; William A Gahl
Journal:  Eur J Hum Genet       Date:  2011-12-07       Impact factor: 4.246

2.  FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

Authors:  Tim W Rattay; Tobias Lindig; Jonathan Baets; Katrien Smets; Tine Deconinck; Anne S Söhn; Konstanze Hörtnagel; Kathrin N Eckstein; Sarah Wiethoff; Jennifer Reichbauer; Marion Döbler-Neumann; Ingeborg Krägeloh-Mann; Michaela Auer-Grumbach; Barbara Plecko; Alexander Münchau; Bernd Wilken; Marc Janauschek; Anne-Katrin Giese; Jan L De Bleecker; Els Ortibus; Martine Debyser; Adolfo Lopez de Munain; Aurora Pujol; Maria Teresa Bassi; Maria Grazia D'Angelo; Peter De Jonghe; Stephan Züchner; Peter Bauer; Ludger Schöls; Rebecca Schüle
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

Review 3.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

4.  Central nervous system dysfunction in a mouse model of FA2H deficiency.

Authors:  Kathleen A Potter; Michael J Kern; George Fullbright; Jacek Bielawski; Steven S Scherer; Sabrina W Yum; Jian J Li; Hua Cheng; Xianlin Han; Jagadish Kummetha Venkata; P Akbar Ali Khan; Bärbel Rohrer; Hiroko Hama
Journal:  Glia       Date:  2011-04-13       Impact factor: 7.452

5.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

Review 6.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks.

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Gabriel Novaes de Rezende Batistella; Thiago Bortholin; Acary Souza Bulle Oliveira
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

7.  Cerebral Iron Accumulation Is Not a Major Feature of FA2H/SPG35.

Authors:  Cecilia Marelli; Mustafa A Salih; Karine Nguyen; Martial Mallaret; Nicolas Leboucq; Hamdy H Hassan; Nathalie Drouot; Pierre Labauge; Michel Koenig
Journal:  Mov Disord Clin Pract       Date:  2015-02-18

Review 8.  Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.

Authors:  F Lamari; F Mochel; F Sedel; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  2012-07-20       Impact factor: 4.982

9.  Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.

Authors:  Monika B Hartig; Arcangela Iuso; Tobias Haack; Tomasz Kmiec; Elzbieta Jurkiewicz; Katharina Heim; Sigrun Roeber; Victoria Tarabin; Sabrina Dusi; Malgorzata Krajewska-Walasek; Sergiusz Jozwiak; Maja Hempel; Juliane Winkelmann; Matthias Elstner; Konrad Oexle; Thomas Klopstock; Wolfgang Mueller-Felber; Thomas Gasser; Claudia Trenkwalder; Valeria Tiranti; Hans Kretzschmar; Gerd Schmitz; Tim M Strom; Thomas Meitinger; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

Review 10.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.